Why the study?
Does screening and sidelining young athletes with high-risk cardiac findings reduce sudden death from cardiac causes?
Does screening and sidelining young athletes with high-risk cardiac findings reduce sudden death from cardiac causes?
Indirect evidence supports the practice of screening and sidelining young athletes with high-risk cardiac findings to prevent sudden cardiac death.
Answers are grounded in this paper and cite their sources.
Supports athlete screening for HCM; leaves open confirmation of sudden-death reduction in randomized studies.
This article summarizes the available information regarding the cardiac risks of participation in athletics. Hypertrophic cardiomyopathy remains the leading cause of sudden death from cardiac causes among young athletes. Although controlled studies are lacking, there is indirect evidence to suggest that screening and sidelining young athletes with high-risk cardiac findings are justified and should decrease the number of sudden deaths in this population.
No takes yet. Share an insight, caveat, or question.
Barry J. Maron (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: